|Comparative efficacy and safety of antidiabetic drug regimens added to metformin monotherapy in patients with type 2 diabetes: a network meta-analysis|
ES Mearns, DM Sobieraj, CM White, WJ Saulsberry, CG Kohn, Y Doleh, ...
PloS one 10 (4), e0125879, 2015
|Quality of vitamin K antagonist control and outcomes in atrial fibrillation patients: a meta-analysis and meta-regression|
ES Mearns, CM White, CG Kohn, J Hawthorne, JS Song, J Meng, ...
Thrombosis journal 12 (1), 1-20, 2014
|Prognostic accuracy of clinical prediction rules for early post-pulmonary embolism all-cause mortality: a bivariate meta-analysis|
CG Kohn, ES Mearns, MW Parker, AV Hernandez, CI Coleman
Chest 147 (4), 1043-1062, 2015
|Cost-effectiveness of immune checkpoint inhibition in BRAF wild-type advanced melanoma|
CG Kohn, SB Zeichner, Q Chen, AJ Montero, DA Goldstein, CR Flowers
Journal of Clinical Oncology 35 (11), 1194, 2017
|Meta-analysis to assess the quality of international normalized ratio control and associated outcomes in venous thromboembolism patients|
ES Mearns, CG Kohn, JS Song, J Hawthorne, J Meng, CM White, ...
Thrombosis research 134 (2), 310-319, 2014
|Impact of mobility impairment on indirect costs and health-related quality of life in multiple sclerosis|
CI Coleman, MF Sidovar, MS Roberts, C Kohn
PloS one 8 (1), e54756, 2013
|Efficacy and safety of antihyperglycaemic drug regimens added to metformin and sulphonylurea therapy in type 2 diabetes: a network meta‐analysis|
ES Mearns, WJ Saulsberry, CM White, CG Kohn, S Lemieux, A Sihabout, ...
Diabetic Medicine 32 (12), 1530-1540, 2015
|Cost-effectiveness analysis of 1st through 3rd line sequential targeted therapy in HER2-positive metastatic breast cancer in the United States|
V Diaby, G Adunlin, AA Ali, SB Zeichner, G de Lima Lopes, CG Kohn, ...
Breast cancer research and treatment 160 (1), 187-196, 2016
|Walking speed and health‐related quality of life in multiple sclerosis|
CG Kohn, WL Baker, MF Sidovar, CI Coleman
The Patient-Patient-Centered Outcomes Research 7 (1), 55-61, 2014
|Estimating a minimal clinically important difference for the EuroQol 5-Dimension health status index in persons with multiple sclerosis|
CG Kohn, MF Sidovar, K Kaur, Y Zhu, CI Coleman
Health and Quality of Life Outcomes 12 (1), 1-5, 2014
|Index clinical manifestation of venous thromboembolism predicts early recurrence type and frequency: a meta‐analysis of randomized controlled trials|
ES Mearns, CI Coleman, D Patel, WJ Saulsberry, A Corman, D Li, ...
Journal of Thrombosis and Haemostasis 13 (6), 1043-1052, 2015
|Impact of angina frequency on health utility values of patients with chronic stable angina|
CG Kohn, MW Parker, BL Limone, CI Coleman
Health and quality of life outcomes 12 (1), 1-6, 2014
|Mobility, walking and physical activity in persons with multiple sclerosis|
CG Kohn, CI Coleman, C Michael White, MF Sidovar, DM Sobieraj
Current Medical Research and Opinion 30 (9), 1857-1862, 2014
|Cost and inpatient burden of peripheral artery disease: Findings from the National Inpatient Sample|
CG Kohn, MJ Alberts, WF Peacock, TJ Bunz, CI Coleman
Atherosclerosis 286, 142-146, 2019
|External validation of the Hestia criteria for identifying acute pulmonary embolism patients at low risk of early mortality|
ER Weeda, CG Kohn, WF Peacock, GJ Fermann, C Crivera, JR Schein, ...
Clinical and Applied Thrombosis/Hemostasis 23 (7), 769-774, 2017
|Correlates of drug use and driving among undergraduate college students|
C Kohn, H Saleheen, K Borrup, S Rogers, G Lapidus
Traffic injury prevention 15 (2), 119-124, 2014
|Validation of the multivariable In-hospital Mortality for PulmonAry embolism using Claims daTa (IMPACT) prediction rule within an all-payer inpatient administrative claims database|
CI Coleman, CG Kohn, C Crivera, JR Schein, WF Peacock
BMJ open 5 (10), e009251, 2015
|Cost-effectiveness of ranolazine added to standard-of-care treatment in patients with chronic stable angina pectoris|
CG Kohn, MW Parker, BL Limone, CI Coleman
The American journal of cardiology 113 (8), 1306-1311, 2014
|The non-medical switching of prescription medications|
R Dolinar, CG Kohn, F Lavernia, E Nguyen
Postgraduate Medicine 131 (5), 335-341, 2019
|Wearable cardioverter-defibrillators for the prevention of sudden cardiac death: a meta-analysis|
E Nguyen, ER Weeda, CG Kohn, BA D’Souza, AM Russo, S Noreika, ...
The Journal of Innovations in Cardiac Rhythm Management 9 (5), 3151, 2018